Skip to main content

JDRF is undergoing a transformation.
We are becoming Breakthrough T1D in October.

breakthrought1d logo
JDRF

JDRF announces new Board appointments

JDRF logo placeholder for author profile picture
Kate Lawton 1 June 2023
Nadia Swann, Wilson Leech and Sarah Johnson

Nadia Swann, Wilson Leech and Sarah Johnson

We’re pleased to announce the appointment of two new Board Directors, Nadia Swann and Sarah Johnson. Existing Board Director Wilson Leech has also been promoted to the position of Vice Chair of the Board. These new appointments come as we celebrate National Volunteers’ week and recognises the contribution of our volunteers to our success.

Sarah Johnson is currently Head of Patient Advocacy, EMEA at IQVIA, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry dedicated to delivering actionable insights. Through her work, she has built collaborations with patient organisations and charities, which have a positive impact on the communities that they jointly serve. Until 2018, Sarah was JDRF’s Director of Mission.

Nadia Swann is a former law firm partner with 20 years’ experience in financial regulation, now at the University of Oxford.

JDRF CEO Karen Addington said: “We are absolutely thrilled to announce the appointment of Nadia Swann and Sarah Johnson as new Directors of the JDRF UK Board of Directors. Their exceptional skills, expertise, and deep commitment to our cause will bolster our efforts in improving the lives of everyone with type 1 diabetes.

“Additionally, I am delighted to congratulate Wilson Leech on his well-deserved promotion to Vice Chair of the Board. With his extensive experience and proven leadership within our organisation, Wilson will guide us towards greater achievements. As we celebrate National Volunteers Week, we extend our heartfelt gratitude to our incredible volunteers who continue to be the backbone of our work, moving us closer to a world free from type 1 diabetes.”

Driving positive change

Wilson said: “It is an honour to take on the role of Vice Chair for JDRF Board of Directors. I am passionate about making a meaningful difference in the lives of individuals and families affected by type 1 diabetes. Together with the dedicated board members, staff, and volunteers, I am committed to furthering JDRF mission and driving positive change in the fight against this complex condition.”

Nadia said: “Our family have lived with type 1 diabetes for three generations and have been greatly helped by the progress made in treatments and technologies over that time. I am passionate about supporting all aspects of research into type 1 diabetes and ensuring the next generation of families get access to transformative technologies. I am very grateful to be able to contribute to the work of JDRF by serving on the Board.”

Sarah added: “I’m extremely proud of what JDRF and the type 1 community have achieved together, and of JDRF’s tremendous progress over the past few years toward improved treatments and bringing us ever closer to cures. I’m delighted to join as a volunteer to contribute again in a small way to achieving a world without type 1 diabetes.”

Related news

Read more
Breakthrough T1D, formally JDRF
JDRF
4 June 2024

JDRF UK to become Breakthrough T1D in major international rebrand

The leading global type 1 diabetes charity, JDRF International (JDRF) is proud to unveil its new brand and name, Breakthrough T1D. The new name embodies its mission to cure and treat type 1 diabetes (T1D), while supporting everyone who lives with the condition.

Read more
Dr Gavin Bewick, a type 1 diabetes researcher working on developing a drug to protect beta cells, in his lab.
Research
12 December 2023

2023 in review – a year of progress and breakthroughs

It's been an incredible year for advancements in type 1 diabetes research and treatments. We take a look at the progress we made in 2023, funded by you, our supporters. 

Read more
JDRF's 2022 in review
JDRF
21 December 2022

Our 2022 Year in Review

A lot has happened over the last 12 months at JDRF, and in the world of type 1 diabetes as a whole. From research breakthroughs to herculean fundraising efforts, here’s a retrospective of everything we’ve been celebrating in 2022.

Read more
Terence Lovell, JDRF UK's fundraising and engagement director
JDRF
9 November 2022

JDRF UK appoints Terence Lovell as Fundraising and Engagement Director

We are delighted to welcome Terence Lovell as Director of Fundraising and Engagement. Terence has worked in the not-for-profit sector for over 20 years.